Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.22B 591M 508M 476M 436M 821M 56.43B 824M 5.63B 2.19B 28.47B 2.17B 94.2B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.25B 599M 514M 482M 441M 832M 57.18B 835M 5.71B 2.22B 28.84B 2.2B 95.45B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+2.17%
1 week+7.00%
Current month+9.78%
1 month+6.37%
3 months+6.73%
6 months+6.46%
Current year-0.15%
1 week 58.85
Extreme 58.85
63.45
1 month 57.55
Extreme 57.55
63.45
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Chairman 54 10/04/2022
Director/Board Member 45 13/09/2023
Director/Board Member 45 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%+7.00%-14.26% - 579M
-1.17%-0.03%+18.70%+70.05% 48.37B
+1.12%+1.41%+54.88%+122.68% 39.88B
-1.36%-1.36%-11.21%+14.14% 12.05B
+2.27%+4.12%+16.41%+81.30% 11.77B
+0.19%0.00%+30.98%+150.00% 9.19B
-0.45%+3.26%+24.53%+45.36% 7.87B
+1.30%+1.26%+54.43%-10.73% 7.25B
+1.60%+8.54%+25.00%+217.84% 7.1B
+0.95%-8.22%-39.88%+16.67% 5.26B
Average +0.66%+1.14%+15.96%+78.59% 14.93B
Weighted average by Cap. +0.16%+1.18%+26.67%+85.38%

Financials

2024 2025
Net sales 394M 105M 90.06M 84.47M 77.27M 146M 10.01B 146M 999M 388M 5.05B 385M 16.71B 460M 123M 105M 98.73M 90.31M 170M 11.7B 171M 1.17B 453M 5.9B 450M 19.53B
Net income 79.85M 21.27M 18.25M 17.12M 15.66M 29.51M 2.03B 29.64M 203M 78.61M 1.02B 78.11M 3.39B 97.01M 25.84M 22.18M 20.8M 19.03M 35.85M 2.47B 36.01M 246M 95.51M 1.24B 94.9M 4.11B
Net Debt 42.83M 11.41M 9.79M 9.18M 8.4M 15.83M 1.09B 15.9M 109M 42.17M 549M 41.9M 1.82B 29.47M 7.85M 6.74M 6.32M 5.78M 10.89M 749M 10.94M 74.75M 29.02M 378M 28.83M 1.25B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26/08/26 SAR 63.45 +2.17% 153,124
25/08/26 SAR 62.10 -1.04% 74,011
24/08/26 SAR 62.75 +1.21% 157,698
23/08/26 SAR 62.00 +0.81% 106,139
20/08/26 SAR 61.50 +3.71% 185,854
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
63.45SAR
Average target price
146.40SAR
Spread / Average Target
+130.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock